We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neuromuscular Ultrasound for Focal Neuropathies

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01394822
First Posted: July 14, 2011
Last Update Posted: November 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Wake Forest University Health Sciences ( Wake Forest University )
July 13, 2011
July 14, 2011
November 6, 2017
September 2011
March 2014   (Final data collection date for primary outcome measure)
Overall Neuropathy Sum Score [ Time Frame: 6 months ]
Neuropathy specific scale
Not Provided
Complete list of historical versions of study NCT01394822 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Neuromuscular Ultrasound for Focal Neuropathies
Neuromuscular Ultrasound for Focal Neuropathies
The purpose of this study is to determine if a new diagnostic technique, called neuromuscular ultrasound, can improve our ability to diagnose focal nerve disease.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Individuals presenting to the Diagnostic Neurology Laboratory at Wake Forest Baptist Medical Center for evaluation of focal nerve disease.
  • Focal Neuropathies
  • Carpal Tunnel Syndrome
  • Cubital Tunnel Syndrome
  • Median Neuropathy
  • Ulnar Neuropathy
  • Peroneal Neuropathy
  • Radial Neuropathy
  • Sciatic Neuropathy
  • Tibial Neuropathy
Not Provided
  • Ultrasound results reported
  • Ultrasound results NOT reported
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
120
March 2014
March 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Electrodiagnostic finding of focal nerve disease
  • Age 18 and older

Exclusion Criteria:

  • Skin lesions preventing ultrasound
  • Known ultrasound gel allergy
  • Unable to complete 6 months of follow-up
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01394822
NINDS-K23NS062892
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Not Provided
Wake Forest University Health Sciences ( Wake Forest University )
Wake Forest University
Not Provided
Principal Investigator: Michael S Cartwright Wake Forest University Health Sciences
Wake Forest University Health Sciences
December 2014